Clinical Trial

Peritoneal Transport With a New Bicarbonate-based Peritoneal Dialysis Solution Compared to Conventional Solution.

Completed Phase 3
View on ClinicalTrials.gov →
Summary
Cross-over study. Patients treated with peritoneal dialysis are investigated twice with a single 4h dwell study: once with Bicarbonate-Lactate solution as buffer (Physioneal TM) and once with conventional lactate PD solution (Dianeal TM). Radioidinated human serum albumin is used as a volume marker to assess ultrafiltration and frequent dialysis and blood sampling to assess peritneal transport of solutes and pH changes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-29.
Trial Details
NCT Number NCT07621627
Lead Sponsor Karolinska Institutet
Conditions Chronic Renal Failure (CRF), Dialysis Dependent Chronic Kidney Disease
Enrollment 7 participants
Start Date 1997-09-09
Primary Completion 1997-11-13 (estimated)
Study Completion 1997-11-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-04